Drugmakers admit UK antitrust breach
Two pharmaceutical companies have admitted to illegally sharing information to maintain high prices in the UK for an antidepressant drug.
To read more
Subscribe to Global Competition Review
Subscribe to unlock unlimited access
Get news, unique commentary, expert analysis and essential resources from the Global Competition Review experts.